Vir Biotechnology, Inc.
SEC 4 · Filed
0001628280-26-038962Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date May 27, 2026
Grant, award or other acquisition by Farid Ramy
- Security
- Stock Option (Right to Buy)
- Shares
-
16,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-05-27",
"direction": "A",
"exercise_price": "9.10",
"expiration": "2036-05-26",
"footnotes": {
"F3": "The shares subject to the stock option will vest and become exercisable in full on May 27, 2027."
},
"owners": [
{
"cik": "0001797707",
"name": "Farid Ramy",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "16000",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Option (Right to Buy)",
"shares": "16000",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "16000"
}Insider transactionsEvent date May 27, 2026
Grant, award or other acquisition by Farid Ramy
- Security
- Common Stock
- Shares
-
8,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-05-27",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Acquisition of restricted stock units (RSUs) pursuant to the Issuer\u0027s Equity Incentive Plan.",
"F2": "The RSUs will vest in full on May 27, 2027."
},
"owners": [
{
"cik": "0001797707",
"name": "Farid Ramy",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "32000",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "8000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}